News
17d
MedPage Today on MSNNovel DPP-1 Drug Trims Exacerbation Risk in BronchiectasisTreatment with brensocatib also increased time to the first exacerbation and the proportion of patients remaining ...
Clinical Brief: Causes and Management of Bronchiectasis Exacerbations Main Discussion Topics Exacerbations are commonly triggered by bacterial infections, viral etiologies, and environmental factors.
In bronchiectasis, the walls of the airways become thickened and damaged as a result of a cycle of inflammation and infections. It is characterised by repeated exacerbations or attacks ...
In bronchiectasis, the walls of the airways become thickened and damaged as a result of a cycle of inflammation and infections. It is characterised by repeated exacerbations or attacks ...
A total of 1,680 adults and 41 adolescents were randomly assigned to brensocatib or placebo. The researchers found that the annualized rate of pulmonary exacerbations was 1.02, 1.04, and 1.29 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results